Nataliya Agafonova - Jul 15, 2025 Form 4 Insider Report for Longeveron Inc. (LGVN)

Role
Chief Medical Officer
Signature
/s/ Paul Lehr, attorney-in-fact
Stock symbol
LGVN
Transactions as of
Jul 15, 2025
Transactions value $
$0
Form type
4
Date filed
7/17/2025, 07:46 PM
Previous filing
Jul 3, 2025
Next filing
Oct 3, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Agafonova Nataliya Chief Medical Officer 1951 NW 7TH AVENUE, SUITE 520, MIAMI /s/ Paul Lehr, attorney-in-fact 2025-07-17 0001985443

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction LGVN Class A Common Stock Award $0 +102K +74.62% $0.00 239K Jul 15, 2025 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LGVN Stock Option (right to buy) Award $0 +34K $0.00 34K Jul 15, 2025 Class A Common Stock 34K $1.47 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the award of time-based vesting Restricted Stock Units (RSUs).
F2 Includes RSUs subject to future vesting.
F3 The option vests quarterly over a three year period beginning on October 1, 2025.